Overview | Medtronic

Creating Long-Term Shareholder Value

Medtronic is uniquely positioned to create long-term value in healthcare. The combination of Medtronic and Covidien creates a robust, market-leading medical technology and services company with a comprehensive product portfolio, broad geographic reach, and diversified growth profile. We believe Covidien meaningfully complements and accelerates our three primary strategies - therapy innovation, globalization, and economic value. We are focused on delivering a strong launch cadence of leading healthcare innovation, addressing the inequity in healthcare access globally, and becoming a leader in the changing value-based healthcare landscape with offerings that deliver both clinical and economic value to a broader set of partners around the world, including physicians, hospital systems, payers, governments, and patients. The addition of Covidien is expected to not only strengthen our long-term market competitiveness, but also increase our financial strength and capital deployment flexibility, driving further sustainability and consistency in our long-term performance. We believe that execution and reliable performance, combined with our disciplined allocation of capital, will create long-term value for our shareholders.

Latest Investor Information

October 14, 2015
Cardiac & Vascular Group Investor Briefing
September 17, 2015
Medtronic plc at the Morgan Stanley Global Healthcare Conference
September 03, 2015
Q1 2016 Medtronic plc Earnings Conference Call

Latest Press Releases

October 08, 2015Medtronic TYRX(TM) Neuro Absorbable Antibacterial Envelope now Available for Use with Implantable Neurostimulators
October 06, 2015Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015
October 05, 2015Medtronic's Valiant® Thoracic Stent Graft System Demonstrates Durability After Five Years
October 02, 2015Medtronic Completes Acquisition of Twelve, Inc.
Read More

Sustainability Index Endorsements

Read more about our Sustainability efforts.


Medtronic Spotlight

CNBC’s Meg Tirrell sits down with Medtronic CEO from the Piper Heartland Conference. (Hosted on CNBC.com)

Play Video

Focus on Patients

The personal connection between Medtronic plc, its employees and patients.

Play Video

History of Medtronic

A video history of the company.

Play Video

Investor Contacts

Stock Transfer Agent

Wells Fargo Shareowner Services
+1 888-648-8154

Medtronic Investor Relations Department


+1 763-505-2692

Ryan Weispfenning

Vice President, Investor Relations

View All